Holdings (Monthly)
Guide ↗
BlackRock Health Sciences Opportunities Portfolio
· BlackRock Funds| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY & COMPANY | LLY | Feb 2026 | 656,650 | -47,692 | $725.6M | -2.1% | 12.29% | EC |
| 2 | JOHNSON & JOHNSON | JNJ | Feb 2026 | 2,299,215 | -389,116 | $518.1M | -22.4% | 8.77% | EC |
| 3 | ABBVIE INC | ABBV | Feb 2026 | 1,068,019 | -89,681 | $232.5M | -13.5% | 3.94% | EC |
| 4 | DANAHER CORP | DHR | Feb 2026 | 645,138 | -71,054 | $117.8M | -21.9% | 2.00% | EC |
| 5 | INTUITIVE SURGICAL INC | ISRG | Feb 2026 | 271,432 | -47,619 | $115.3M | -28.3% | 1.95% | EC |
| 6 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Feb 2026 | 3,121,339 | -353,754 | $110.2M | -6.3% | 1.87% | EC |
| 7 | ARGENX SE | ARGX | Feb 2026 | 88,995 | -32,345 | $74.4M | -20.1% | 1.26% | EC |
| 8 | STRYKER CORP | SYK | Feb 2026 | 221,948 | -111,123 | $67.7M | -47.5% | 1.15% | EC |
| 9 | BRISTOL-MYERS SQUIBB COMPANY | BMY | Feb 2026 | 917,026 | -180,058 | $52.4M | -23.4% | 0.89% | EC |
| 10 | HCA HEALTHCARE INC | HCA | Feb 2026 | 111,627 | -14,078 | $42.3M | -36.5% | 0.72% | EC |
| 11 | RHYTHM PHARMACEUTICALS INC | RYTM | Feb 2026 | 471,276 | -67,517 | $41.6M | -16.7% | 0.70% | EC |
| 12 | IDEXX LABORATORIES INC | IDXX | Feb 2026 | 65,102 | -9,519 | $36.7M | -25.1% | 0.62% | EC |
| 13 | ALNYLAM PHARMACEUTICALS INC | ALNY | Feb 2026 | 94,913 | -112,236 | $28.7M | -58.4% | 0.49% | EC |
| 14 | MEDLINE INC | MDLN | Feb 2026 | 605,149 | -237,424 | $22.1M | -44.7% | 0.37% | EC |
| 15 | BLACKROCK LIQUIDITY FUNDS | TSTXX | Feb 2026 | 21,272,201 | -12,923,669 | $21.3M | -37.8% | 0.36% | STIV |
| 16 | MCKESSON CORP | MCK | Feb 2026 | 27,586 | -52,076 | $20.5M | -74.0% | 0.35% | EC |
| 17 | CENCORA INC | COR | Feb 2026 | 46,310 | -219,550 | $12.5M | -87.4% | 0.21% | EC |
| 18 | WEST PHARMACEUTICAL SERVICES INC | WST | Feb 2026 | 32,517 | -27,912 | $10.5M | -31.7% | 0.18% | EC |
| 19 | NATERA INC | NTRA | Feb 2026 | 46,190 | -84,089 | $10.3M | -61.9% | 0.17% | EC |
| 20 | AGIOS PHARMACEUTICALS INC | AGIO | Feb 2026 | 271,615 | -73,261 | $8.0M | -23.4% | 0.14% | EC |
| 21 | BRIDGEBIO PHARMA INC | BBIO | Feb 2026 | 86,968 | -117,906 | $5.8M | -57.7% | 0.10% | EC |
| 22 | DENALI THERAPEUTICS INC | DNLI | Feb 2026 | 251,859 | -77,320 | $5.3M | -24.0% | 0.09% | EC |
| 23 | SUMMIT THERAPEUTICS INC | SMMT | Feb 2026 | 276,987 | -647,161 | $4.9M | -68.3% | 0.08% | EC |
| 24 | KODIAK SCIENCES INC | KOD | Feb 2026 | 128,647 | -60,122 | $4.7M | -6.6% | 0.08% | EC |
| 25 | PTC THERAPEUTICS INC | PTCT | Feb 2026 | 48,954 | -34,016 | $3.6M | -36.1% | 0.06% | EC |